Semin Reprod Med 2002; 20(3): 169-180
DOI: 10.1055/s-2002-35381
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Molecular Endocrinology of Sex Differentiation

Garry L. Warne, Shankar Kanumakala
  • Centre for Hormone Research, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia
Further Information

Publication History

Publication Date:
12 November 2002 (online)

ABSTRACT

Differentiation of a testis or an ovary from a bipotential gonad is a complex developmental process involving various genes and hormones. Similarly, internal and external genital organs develop from an indeterminate stage from the complex differentiation of Wolffian and Müllerian ducts. Differentiation of the Wolffian ducts, urogenital sinus, and external genitalia is androgen dependent. Female sex differentiation appears to be a more passive process that is independent of estrogen. This article reviews the process of differentiation of the gonads and the genitalia and the factors affecting it. In addition, a clinical approach to patients with sexual ambiguity or sex reversal is discussed.

REFERENCES

  • 1 Segaloff D L, Ascoli M. The lutropin/chorionic gonadotropin receptor: 4 years later.  Endocr Rev . 1993;  14 324-347
  • 2 de Roux N, Milgrom E. Inherited disorders of GnRH and gonadotropin receptors.  Mol Cell Endocrinol . 2001;  179 83-87
  • 3 Aittomaki K, Hreva R, Stenman U-H. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene.  J Clin Endocrinol Metab . 1996;  81 3722-3726
  • 4 Boehmer A L, Brinkmann A O, Sandkuijl L A. 17Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations.  J Clin Endocrinol Metab . 1999;  84 4713-4721
  • 5 Shaw G, Renfree M B, Leihy M W. Prostate formation in a marsupial is mediated by the testicular androgen 5α-androstane-3α,17β-diol.  Proc Natl Acad Sci U S A . 2000;  97 12256-12259
  • 6 Chetyrkin S V, Hu J, Gough W H, Dumaual N, Kedishvili N Y. Further characterization of human microsomal 3alpha-hydroxysteroid dehydrogenase.  Arch Biochem Biophys . 2001;  386 1-10
  • 7 Shozu M, Akasofu K, Harada T, Kubota Y. A new cause of female pseudohermaphroditism: placental aromatase deficiency.  J Clin Endocrinol Metab . 1991;  72 560-566
  • 8 Grumbach M M, Auchus R J. Estrogen: consequences and implications of human mutations in synthesis and action.  J Clin Endocrinol Metab . 1999;  84 4677-4694
  • 9 Chamberlain N L, Driver E D, Miesfeld R L. The length and location of the CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function.  Nucleic Acids Res . 1994;  22 3181-3186
  • 10 Bratt O, Borg A, Kristoffersson U. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk.  Br J Cancer . 1999;  81 672-676
  • 11 Ishii T, Sato S, Kosaki K. Micropenis and the AR gene: mutation and CAG repeat-length analysis.  J Clin Endocrinol Metab . 2001;  86 5372-5378
  • 12 Lobaccaro J M, Lumbroso S, Poujol N, Belon C, Sultan C. Molecular genetics of androgen insensitivity syndromes.  Cell Mol Biol . 1994;  40 301-308
  • 13 Boehmer A L, Bruggenwirth H, van Assendelft C. Genotype versus phenotype in families with androgen insensitivity syndrome.  J Clin Endocrinol Metab . 2001;  86 4151-4160
  • 14 Josso N, di Clemente N, Gouédard L. Anti-Müllerian hormone and its receptors.  Mol Cell Endocrinol . 2001;  179 25-32
  • 15 Arango N A, Lovell-Badge R, Behringer R R. Targeted mutagenesis of the endogenous mouse Mis gene promoter: in vivo definition of genetic pathways of vertebrate sexual development.  Cell . 1999;  99 409-419
  • 16 Tremblay J J, Viger R S. Transcription factor GATA-4 enhances Müllerian inhibitory substance gene transcription through a direct interaction with the nuclear receptor SF-1.  Mol Endocrinol . 1999;  13 1388-1401
  • 17 Allard S, Adin P, Gouédard L. Molecular mechanisms of hormone-related Mullerian duct regression: involvement of β-catenin.  Development . 2000;  127 3349-3360
  • 18 Imbéaud S, Belville C, Messika-Zeitoun L. A 27 base-pair deletion of the anti-Müllerian type II receptor gene is the most common cause of the persistent Müllerian duct syndrome.  Hum Mol Genet . 1996;  5 1269-1277
  • 19 Heyns C F, Hutson J M. Historical review of theories on testicular descent.  J Urol . 1995;  153 754-767
  • 20 O'Connell H E, Hutson J M, Anderson C R, Plenter R J. Anatomical relationship between urethra and clitoris.  J Urol . 1998;  159 1892-1897
  • 21 Folch M, Pigem I, Konje J C. Mullerian agenesis: etiology, diagnosis, and management.  Obstet Gynecol Surv . 2000;  55 644-649
  • 22 Hamerton J L, Canning N, Ray M, Smith S. A cytogenetic survey of 14,069 newborn infants: I. Incidence of chromosome abnormalities.  Clin Genet . 1975;  8 223-243
  • 23 Creighton S M, Minto C L, Steele S J. Objective cosmetic and anatomical outcomes at adolescence of feminising surgery for ambiguous genitalia done in childhood.  Lancet . 2001;  358 124-125
  • 24 May B, Boyle M, Grant D B. A comparative study of sexual experiences: women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.  J Health Psychol . 1996;  1 479-492
  • 25 Woodhouse C R. The sexual and reproductive consequences of congenital urinary abnormalities.  J Urol . 1994;  152 645-651
  • 26 Diamond M, Sigmundson H K. Management of intersexuality: guidelines for dealing with persons with ambiguous genitalia.  Arch Pediatr Adolesc Med . 1997;  151 1046-1050
  • 27 Gourlay W A, Johnson H W, Pantzar J TM. Gonadal tumors in disorders of sexual differentiation.  Urology . 1994;  43 537-540
  • 28 Slowikowska-Hilczer J, Szarras-Czapnik M, Kula K. Testicular pathology in 46,XY dysgenetic male pseudohermaphroditism: an approach to pathogenesis of testis cancer.  J Androl . 2001;  22 781-792
    >